Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Deichmann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
American Journal of Human Genetics|March 20, 2012
Mutations in ROGDI Cause Kohlschütter-Tönz SyndromeAnna Schossig, Nicole I Wolf, Christine Fischer, et al.
Current Gene Therapy|November 28, 2014
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell diseaseOlivier Negre, Cynthia Bartholomae, Yves Beuzard, et al.
Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.
The Journal of Clinical Investigation|August 3, 2007
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivoKerstin Schwarzwaelder, Steven J Howe, Manfred Schmidt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.
The Journal of Clinical Investigation|August 3, 2007
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapyAnnette Deichmann, Salima Hacein-Bey-Abina, Manfred Schmidt, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
American Journal of Human Genetics|March 20, 2012
Mutations in ROGDI Cause Kohlschütter-Tönz SyndromeAnna Schossig, Nicole I Wolf, Christine Fischer, et al.
Current Gene Therapy|November 28, 2014
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell diseaseOlivier Negre, Cynthia Bartholomae, Yves Beuzard, et al.
Nature Medicine|April 4, 2006
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Marion G Ott, Manfred Schmidt, Kerstin Schwarzwaelder, et al.
The Journal of Clinical Investigation|August 3, 2007
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivoKerstin Schwarzwaelder, Steven J Howe, Manfred Schmidt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.
The Journal of Clinical Investigation|August 3, 2007
Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapyAnnette Deichmann, Salima Hacein-Bey-Abina, Manfred Schmidt, et al.
Pageof 2